

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 5.60921183 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 5.60921183 |
| 3 | COPII vesicle coating (GO:0048208) | 5.22986482 |
| 4 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 5.08315302 |
| 5 | exocrine pancreas development (GO:0031017) | 5.00678455 |
| 6 | high-density lipoprotein particle remodeling (GO:0034375) | 4.85118212 |
| 7 | signal peptide processing (GO:0006465) | 4.82154006 |
| 8 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.70901061 |
| 9 | endocrine pancreas development (GO:0031018) | 4.58738950 |
| 10 | ER overload response (GO:0006983) | 4.48781154 |
| 11 | reverse cholesterol transport (GO:0043691) | 4.43321175 |
| 12 | L-phenylalanine catabolic process (GO:0006559) | 4.42965927 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.42965927 |
| 14 | plasma lipoprotein particle assembly (GO:0034377) | 4.36576156 |
| 15 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.32979535 |
| 16 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 4.29481550 |
| 17 | regulation of cholesterol esterification (GO:0010872) | 4.29309166 |
| 18 | sequestering of metal ion (GO:0051238) | 4.22664394 |
| 19 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.21832206 |
| 20 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 4.21740890 |
| 21 | negative regulation of protein activation cascade (GO:2000258) | 4.15161407 |
| 22 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 4.03701396 |
| 23 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.95389066 |
| 24 | L-phenylalanine metabolic process (GO:0006558) | 3.95389066 |
| 25 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.88580677 |
| 26 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.87426628 |
| 27 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.84043588 |
| 28 | Sertoli cell development (GO:0060009) | 3.83060124 |
| 29 | phospholipid efflux (GO:0033700) | 3.79370817 |
| 30 | transcytosis (GO:0045056) | 3.77220868 |
| 31 | cholesterol efflux (GO:0033344) | 3.69991621 |
| 32 | intestinal cholesterol absorption (GO:0030299) | 3.69332719 |
| 33 | plasma lipoprotein particle remodeling (GO:0034369) | 3.68690498 |
| 34 | protein-lipid complex remodeling (GO:0034368) | 3.68690498 |
| 35 | macromolecular complex remodeling (GO:0034367) | 3.68690498 |
| 36 | aromatic amino acid family catabolic process (GO:0009074) | 3.67838863 |
| 37 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.67108570 |
| 38 | inner ear receptor cell differentiation (GO:0060113) | 3.66708578 |
| 39 | genitalia morphogenesis (GO:0035112) | 3.66068660 |
| 40 | peptide hormone processing (GO:0016486) | 3.65419130 |
| 41 | glandular epithelial cell differentiation (GO:0002067) | 3.61686387 |
| 42 | cellular response to unfolded protein (GO:0034620) | 3.61342866 |
| 43 | positive regulation of nuclease activity (GO:0032075) | 3.59467268 |
| 44 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.54094604 |
| 45 | protein carboxylation (GO:0018214) | 3.54094604 |
| 46 | auditory receptor cell differentiation (GO:0042491) | 3.48925083 |
| 47 | cysteine metabolic process (GO:0006534) | 3.48385789 |
| 48 | ER-nucleus signaling pathway (GO:0006984) | 3.42806670 |
| 49 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.41818639 |
| 50 | centriole replication (GO:0007099) | 3.40212264 |
| 51 | negative regulation of complement activation (GO:0045916) | 3.38087524 |
| 52 | cellular response to topologically incorrect protein (GO:0035967) | 3.37835918 |
| 53 | epithelial cilium movement (GO:0003351) | 3.37450864 |
| 54 | intra-Golgi vesicle-mediated transport (GO:0006891) | 3.32747208 |
| 55 | protein retention in ER lumen (GO:0006621) | 3.30854501 |
| 56 | protein maturation by protein folding (GO:0022417) | 3.28269070 |
| 57 | phospholipid homeostasis (GO:0055091) | 3.26900734 |
| 58 | intraciliary transport (GO:0042073) | 3.26787238 |
| 59 | negative regulation of lipase activity (GO:0060192) | 3.24847099 |
| 60 | response to endoplasmic reticulum stress (GO:0034976) | 3.23127355 |
| 61 | regulation of nuclease activity (GO:0032069) | 3.21824421 |
| 62 | 4-hydroxyproline metabolic process (GO:0019471) | 3.19896600 |
| 63 | cilium movement (GO:0003341) | 3.15892809 |
| 64 | plasma lipoprotein particle organization (GO:0071827) | 3.12620327 |
| 65 | cholesterol biosynthetic process (GO:0006695) | 3.10914941 |
| 66 | tryptophan metabolic process (GO:0006568) | 3.09324029 |
| 67 | axoneme assembly (GO:0035082) | 3.08646265 |
| 68 | retinal metabolic process (GO:0042574) | 3.07252325 |
| 69 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.07164839 |
| 70 | triglyceride homeostasis (GO:0070328) | 3.04810971 |
| 71 | acylglycerol homeostasis (GO:0055090) | 3.04810971 |
| 72 | uronic acid metabolic process (GO:0006063) | 3.04695803 |
| 73 | glucuronate metabolic process (GO:0019585) | 3.04695803 |
| 74 | indole-containing compound catabolic process (GO:0042436) | 3.03167158 |
| 75 | indolalkylamine catabolic process (GO:0046218) | 3.03167158 |
| 76 | tryptophan catabolic process (GO:0006569) | 3.03167158 |
| 77 | cellular ketone body metabolic process (GO:0046950) | 3.02287655 |
| 78 | coenzyme catabolic process (GO:0009109) | 3.00618726 |
| 79 | isoprenoid biosynthetic process (GO:0008299) | 2.99130254 |
| 80 | regulation of fibrinolysis (GO:0051917) | 2.98695923 |
| 81 | phenylpropanoid metabolic process (GO:0009698) | 2.96251165 |
| 82 | sterol biosynthetic process (GO:0016126) | 2.96249470 |
| 83 | histone H3-K4 trimethylation (GO:0080182) | 2.94320951 |
| 84 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.93196651 |
| 85 | regulation of meiosis I (GO:0060631) | 2.93122533 |
| 86 | type B pancreatic cell development (GO:0003323) | 2.90311177 |
| 87 | bile acid metabolic process (GO:0008206) | 2.90276708 |
| 88 | neural tube formation (GO:0001841) | 2.89451323 |
| 89 | nucleotide transmembrane transport (GO:1901679) | 2.89120892 |
| 90 | valine metabolic process (GO:0006573) | 2.88279613 |
| 91 | rRNA catabolic process (GO:0016075) | 2.87230599 |
| 92 | fibrinolysis (GO:0042730) | 2.86685274 |
| 93 | protein localization to Golgi apparatus (GO:0034067) | 2.84839689 |
| 94 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.84672357 |
| 95 | low-density lipoprotein particle remodeling (GO:0034374) | 2.83647008 |
| 96 | * response to unfolded protein (GO:0006986) | 2.83461939 |
| 97 | negative regulation of digestive system process (GO:0060457) | 2.83371732 |
| 98 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.82785250 |
| 99 | protein-lipid complex subunit organization (GO:0071825) | 2.82641556 |
| 100 | aromatic amino acid family metabolic process (GO:0009072) | 2.82173599 |
| 101 | muscle organ morphogenesis (GO:0048644) | 2.81620803 |
| 102 | tyrosine metabolic process (GO:0006570) | 2.77466614 |
| 103 | indolalkylamine metabolic process (GO:0006586) | 2.74899470 |
| 104 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.74688698 |
| 105 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.74316191 |
| 106 | protein targeting to Golgi (GO:0000042) | 2.74309614 |
| 107 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.73947271 |
| 108 | regulation of lipoprotein metabolic process (GO:0050746) | 2.73678975 |
| 109 | vesicle coating (GO:0006901) | 2.72483620 |
| 110 | * response to topologically incorrect protein (GO:0035966) | 2.71983589 |
| 111 | cholesterol transport (GO:0030301) | 2.71946951 |
| 112 | sterol transport (GO:0015918) | 2.71946951 |
| 113 | negative regulation of humoral immune response (GO:0002921) | 2.71604834 |
| 114 | diterpenoid biosynthetic process (GO:0016102) | 2.71378129 |
| 115 | photoreceptor cell differentiation (GO:0046530) | 2.71255315 |
| 116 | eye photoreceptor cell differentiation (GO:0001754) | 2.71255315 |
| 117 | opsonization (GO:0008228) | 2.70617549 |
| 118 | cellular response to ATP (GO:0071318) | 2.69816378 |
| 119 | regulation of cilium movement (GO:0003352) | 2.67951775 |
| 120 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 2.64457093 |
| 121 | negative regulation of cholesterol transport (GO:0032375) | 2.64357265 |
| 122 | negative regulation of sterol transport (GO:0032372) | 2.64357265 |
| 123 | amine catabolic process (GO:0009310) | 2.63557435 |
| 124 | cellular biogenic amine catabolic process (GO:0042402) | 2.63557435 |
| 125 | regulation of protein activation cascade (GO:2000257) | 2.63150092 |
| 126 | ketone body metabolic process (GO:1902224) | 2.62810392 |
| 127 | artery smooth muscle contraction (GO:0014824) | 2.62514849 |
| 128 | Leydig cell differentiation (GO:0033327) | 2.62181119 |
| 129 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.62020713 |
| 130 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.61234213 |
| 131 | retinol metabolic process (GO:0042572) | 2.60203525 |
| 132 | complement activation, alternative pathway (GO:0006957) | 2.60150116 |
| 133 | mitotic sister chromatid cohesion (GO:0007064) | 2.60026264 |
| 134 | regulation of plasminogen activation (GO:0010755) | 2.59845993 |
| 135 | cholesterol homeostasis (GO:0042632) | 2.59752110 |
| 136 | sulfur amino acid catabolic process (GO:0000098) | 2.58790442 |
| 137 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.58614519 |
| 138 | regulation of male gonad development (GO:2000018) | 2.58024920 |
| 139 | drug transmembrane transport (GO:0006855) | 2.57860871 |
| 140 | sterol homeostasis (GO:0055092) | 2.57653693 |
| 141 | bile acid and bile salt transport (GO:0015721) | 2.57240459 |
| 142 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.56901616 |
| 143 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.56552822 |
| 144 | cellular response to vitamin D (GO:0071305) | 2.56393128 |
| 145 | axonemal dynein complex assembly (GO:0070286) | 2.56383608 |
| 146 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.56359218 |
| 147 | macroautophagy (GO:0016236) | 2.55852309 |
| 148 | Golgi to endosome transport (GO:0006895) | 2.54873124 |
| 149 | peptidyl-asparagine modification (GO:0018196) | 2.54330034 |
| 150 | regulation of energy homeostasis (GO:2000505) | 2.54269662 |
| 151 | bile acid biosynthetic process (GO:0006699) | 2.53626467 |
| 152 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.53360193 |
| 153 | intestinal absorption (GO:0050892) | 2.51129452 |
| 154 | phosphatidylcholine biosynthetic process (GO:0006656) | 2.50876186 |
| 155 | branched-chain amino acid catabolic process (GO:0009083) | 2.50354086 |
| 156 | regulation of acrosome reaction (GO:0060046) | 2.49930540 |
| 157 | regulation of hexokinase activity (GO:1903299) | 2.49901826 |
| 158 | regulation of glucokinase activity (GO:0033131) | 2.49901826 |
| 159 | negative regulation of fibrinolysis (GO:0051918) | 2.49620376 |
| 160 | positive regulation of glycolytic process (GO:0045821) | 2.49558901 |
| 161 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.48003698 |
| 162 | intestinal epithelial cell development (GO:0060576) | 2.47917081 |
| 163 | positive regulation of peptide hormone secretion (GO:0090277) | 2.47696029 |
| 164 | imidazole-containing compound metabolic process (GO:0052803) | 2.47396561 |
| 165 | positive regulation of insulin secretion (GO:0032024) | 2.47211926 |
| 166 | regulation of complement activation (GO:0030449) | 2.46949770 |
| 167 | toxin metabolic process (GO:0009404) | 2.45381659 |
| 168 | kynurenine metabolic process (GO:0070189) | 2.43446401 |
| 169 | positive regulation of hormone metabolic process (GO:0032352) | 2.43184782 |
| 170 | cellular glucuronidation (GO:0052695) | 2.41186237 |
| 171 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.40034404 |
| 172 | establishment of protein localization to Golgi (GO:0072600) | 2.39978710 |
| 173 | blood coagulation, intrinsic pathway (GO:0007597) | 2.39952924 |
| 174 | cellular modified amino acid catabolic process (GO:0042219) | 2.39241748 |
| 175 | protein-lipid complex assembly (GO:0065005) | 2.39117093 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.45509468 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.22893874 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.61786820 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.24932903 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.90364993 |
| 6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.86154932 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.79449446 |
| 8 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.71846150 |
| 9 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.71494685 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.35181133 |
| 11 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.33711206 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.21988237 |
| 13 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.19466053 |
| 14 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.12198068 |
| 15 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.11283464 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.97851882 |
| 17 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.90337960 |
| 18 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.89407849 |
| 19 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.88305152 |
| 20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.87400306 |
| 21 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.85759533 |
| 22 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.83007441 |
| 23 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.81130072 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.79747207 |
| 25 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.77662044 |
| 26 | FUS_26573619_Chip-Seq_HEK293_Human | 1.70385371 |
| 27 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.70359947 |
| 28 | VDR_22108803_ChIP-Seq_LS180_Human | 1.69788707 |
| 29 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.67894713 |
| 30 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.67132171 |
| 31 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.66265035 |
| 32 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.64765998 |
| 33 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.64765998 |
| 34 | EWS_26573619_Chip-Seq_HEK293_Human | 1.62657495 |
| 35 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.59687369 |
| 36 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.54704569 |
| 37 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.53132749 |
| 38 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.51581653 |
| 39 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.51151228 |
| 40 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.49796436 |
| 41 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.47763624 |
| 42 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.45744399 |
| 43 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.45744399 |
| 44 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.44270045 |
| 45 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.43353606 |
| 46 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.41328512 |
| 47 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.40312308 |
| 48 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.40284419 |
| 49 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.40217846 |
| 50 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.39796220 |
| 51 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.37915295 |
| 52 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.37815485 |
| 53 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.37813393 |
| 54 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.37371758 |
| 55 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.36743572 |
| 56 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.36554224 |
| 57 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.36321631 |
| 58 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.36102976 |
| 59 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.35004204 |
| 60 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.34972320 |
| 61 | GATA1_22025678_ChIP-Seq_K562_Human | 1.34361624 |
| 62 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.34345993 |
| 63 | AR_25329375_ChIP-Seq_VCAP_Human | 1.33177237 |
| 64 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.31339562 |
| 65 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.31198824 |
| 66 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.29801070 |
| 67 | * ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.29448151 |
| 68 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.27919870 |
| 69 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.27902354 |
| 70 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.24087551 |
| 71 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.23846798 |
| 72 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.22681083 |
| 73 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22521886 |
| 74 | * CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.22085513 |
| 75 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.21669980 |
| 76 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.21349132 |
| 77 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.21164004 |
| 78 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.20971643 |
| 79 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.20156870 |
| 80 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.16536261 |
| 81 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.16121882 |
| 82 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.15019440 |
| 83 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.14765300 |
| 84 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.14627504 |
| 85 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.14442182 |
| 86 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.14060642 |
| 87 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.13713160 |
| 88 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.13437117 |
| 89 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.13384564 |
| 90 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.13232034 |
| 91 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.13232034 |
| 92 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.12334059 |
| 93 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.11769792 |
| 94 | * KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.11721512 |
| 95 | CJUN_26792858_Chip-Seq_BT549_Human | 1.11147559 |
| 96 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.11002867 |
| 97 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10763192 |
| 98 | TP53_16413492_ChIP-PET_HCT116_Human | 1.10359891 |
| 99 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.08667947 |
| 100 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07367327 |
| 101 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.06478258 |
| 102 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.06448678 |
| 103 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.03021470 |
| 104 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.02226070 |
| 105 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.01867492 |
| 106 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.01426667 |
| 107 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.00580753 |
| 108 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.99575417 |
| 109 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98254977 |
| 110 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.97955360 |
| 111 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97030158 |
| 112 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96704916 |
| 113 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.96165271 |
| 114 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.94026968 |
| 115 | * PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.93386799 |
| 116 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.92657070 |
| 117 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.92634175 |
| 118 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.91787155 |
| 119 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.91597419 |
| 120 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91023116 |
| 121 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.90952732 |
| 122 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90510758 |
| 123 | AR_20517297_ChIP-Seq_VCAP_Human | 0.89729541 |
| 124 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.89250267 |
| 125 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.88832340 |
| 126 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.88583820 |
| 127 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.87050625 |
| 128 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.85819802 |
| 129 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.85797641 |
| 130 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.85592167 |
| 131 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.85392980 |
| 132 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.85256711 |
| 133 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.85252779 |
| 134 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85182697 |
| 135 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.84484407 |
| 136 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.84138358 |
| 137 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83831798 |
| 138 | STAT3_23295773_ChIP-Seq_U87_Human | 0.83148241 |
| 139 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.82957946 |
| 140 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.82934483 |
| 141 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.82817547 |
| 142 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.81270781 |
| 143 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.81204806 |
| 144 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.80846708 |
| 145 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.79632021 |
| 146 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.78667646 |
| 147 | P300_19829295_ChIP-Seq_ESCs_Human | 0.77986869 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.73930945 |
| 2 | MP0005365_abnormal_bile_salt | 4.09832925 |
| 3 | MP0003122_maternal_imprinting | 3.79504164 |
| 4 | MP0003195_calcinosis | 3.61357292 |
| 5 | MP0003252_abnormal_bile_duct | 3.31448181 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.19394418 |
| 7 | MP0008877_abnormal_DNA_methylation | 3.13715933 |
| 8 | MP0005220_abnormal_exocrine_pancreas | 3.04944007 |
| 9 | MP0003787_abnormal_imprinting | 2.77147150 |
| 10 | MP0002877_abnormal_melanocyte_morpholog | 2.66462111 |
| 11 | MP0001944_abnormal_pancreas_morphology | 2.60493657 |
| 12 | MP0005360_urolithiasis | 2.59846726 |
| 13 | MP0002693_abnormal_pancreas_physiology | 2.59567455 |
| 14 | MP0002138_abnormal_hepatobiliary_system | 2.56630573 |
| 15 | MP0010386_abnormal_urinary_bladder | 2.55593274 |
| 16 | MP0003868_abnormal_feces_composition | 2.47275878 |
| 17 | MP0003890_abnormal_embryonic-extraembry | 2.45447967 |
| 18 | MP0001666_abnormal_nutrient_absorption | 2.44676600 |
| 19 | MP0005083_abnormal_biliary_tract | 2.42573497 |
| 20 | MP0003121_genomic_imprinting | 2.40455749 |
| 21 | MP0002928_abnormal_bile_duct | 2.21638811 |
| 22 | MP0005379_endocrine/exocrine_gland_phen | 2.11509206 |
| 23 | MP0008875_abnormal_xenobiotic_pharmacok | 2.03572655 |
| 24 | MP0000013_abnormal_adipose_tissue | 1.99947683 |
| 25 | MP0005408_hypopigmentation | 1.88896752 |
| 26 | MP0000566_synostosis | 1.81226704 |
| 27 | MP0003300_gastrointestinal_ulcer | 1.77554025 |
| 28 | MP0000613_abnormal_salivary_gland | 1.72738718 |
| 29 | MP0000383_abnormal_hair_follicle | 1.63212381 |
| 30 | MP0009780_abnormal_chondrocyte_physiolo | 1.61174629 |
| 31 | MP0009384_cardiac_valve_regurgitation | 1.56269176 |
| 32 | MP0000427_abnormal_hair_cycle | 1.51847740 |
| 33 | MP0001661_extended_life_span | 1.49887817 |
| 34 | MP0004264_abnormal_extraembryonic_tissu | 1.46213399 |
| 35 | MP0008438_abnormal_cutaneous_collagen | 1.45407171 |
| 36 | MP0002638_abnormal_pupillary_reflex | 1.45115053 |
| 37 | MP0000516_abnormal_urinary_system | 1.45077017 |
| 38 | MP0005367_renal/urinary_system_phenotyp | 1.45077017 |
| 39 | MP0009643_abnormal_urine_homeostasis | 1.43442526 |
| 40 | MP0010678_abnormal_skin_adnexa | 1.41576540 |
| 41 | MP0002078_abnormal_glucose_homeostasis | 1.38742348 |
| 42 | MP0005248_abnormal_Harderian_gland | 1.38178748 |
| 43 | MP0008057_abnormal_DNA_replication | 1.36904407 |
| 44 | MP0000609_abnormal_liver_physiology | 1.35457369 |
| 45 | MP0000639_abnormal_adrenal_gland | 1.31885228 |
| 46 | MP0010352_gastrointestinal_tract_polyps | 1.31400413 |
| 47 | MP0004043_abnormal_pH_regulation | 1.31168130 |
| 48 | MP0000647_abnormal_sebaceous_gland | 1.29746441 |
| 49 | MP0005636_abnormal_mineral_homeostasis | 1.27608871 |
| 50 | MP0009840_abnormal_foam_cell | 1.27522123 |
| 51 | MP0000569_abnormal_digit_pigmentation | 1.27519088 |
| 52 | MP0005645_abnormal_hypothalamus_physiol | 1.25965455 |
| 53 | MP0006072_abnormal_retinal_apoptosis | 1.25582224 |
| 54 | MP0002163_abnormal_gland_morphology | 1.24268256 |
| 55 | MP0002896_abnormal_bone_mineralization | 1.24147775 |
| 56 | MP0000003_abnormal_adipose_tissue | 1.21298991 |
| 57 | MP0010329_abnormal_lipoprotein_level | 1.20413047 |
| 58 | MP0002282_abnormal_trachea_morphology | 1.20375132 |
| 59 | MP0005332_abnormal_amino_acid | 1.20365171 |
| 60 | MP0002118_abnormal_lipid_homeostasis | 1.18059236 |
| 61 | MP0003943_abnormal_hepatobiliary_system | 1.17883300 |
| 62 | MP0004134_abnormal_chest_morphology | 1.15941038 |
| 63 | MP0002168_other_aberrant_phenotype | 1.15766762 |
| 64 | MP0001765_abnormal_ion_homeostasis | 1.15451438 |
| 65 | MP0005084_abnormal_gallbladder_morpholo | 1.14986034 |
| 66 | MP0003283_abnormal_digestive_organ | 1.13957282 |
| 67 | MP0005058_abnormal_lysosome_morphology | 1.11211622 |
| 68 | MP0002295_abnormal_pulmonary_circulatio | 1.10835740 |
| 69 | MP0005253_abnormal_eye_physiology | 1.10594302 |
| 70 | MP0005409_darkened_coat_color | 1.10359487 |
| 71 | MP0005647_abnormal_sex_gland | 1.09638763 |
| 72 | MP0004381_abnormal_hair_follicle | 1.07951435 |
| 73 | MP0003724_increased_susceptibility_to | 1.07645521 |
| 74 | MP0000462_abnormal_digestive_system | 1.05034984 |
| 75 | MP0002166_altered_tumor_susceptibility | 1.04262198 |
| 76 | MP0003959_abnormal_lean_body | 1.02794735 |
| 77 | MP0005310_abnormal_salivary_gland | 1.02513823 |
| 78 | MP0010368_abnormal_lymphatic_system | 1.01458934 |
| 79 | MP0001986_abnormal_taste_sensitivity | 0.99288965 |
| 80 | MP0003183_abnormal_peptide_metabolism | 0.99083072 |
| 81 | MP0002909_abnormal_adrenal_gland | 0.98809131 |
| 82 | MP0004883_abnormal_blood_vessel | 0.98090466 |
| 83 | MP0002233_abnormal_nose_morphology | 0.97232024 |
| 84 | MP0001485_abnormal_pinna_reflex | 0.96817521 |
| 85 | MP0002060_abnormal_skin_morphology | 0.94294453 |
| 86 | MP0003045_fibrosis | 0.94035364 |
| 87 | MP0009697_abnormal_copulation | 0.93476267 |
| 88 | MP0004142_abnormal_muscle_tone | 0.93183567 |
| 89 | MP0001188_hyperpigmentation | 0.92005480 |
| 90 | MP0003795_abnormal_bone_structure | 0.90992191 |
| 91 | MP0003191_abnormal_cellular_cholesterol | 0.90868094 |
| 92 | MP0001879_abnormal_lymphatic_vessel | 0.89098276 |
| 93 | MP0002837_dystrophic_cardiac_calcinosis | 0.88597579 |
| 94 | MP0001756_abnormal_urination | 0.87557336 |
| 95 | MP0005395_other_phenotype | 0.87351709 |
| 96 | MP0001984_abnormal_olfaction | 0.87193846 |
| 97 | MP0005319_abnormal_enzyme/_coenzyme | 0.87061491 |
| 98 | MP0005334_abnormal_fat_pad | 0.84585836 |
| 99 | MP0005670_abnormal_white_adipose | 0.84466681 |
| 100 | MP0005257_abnormal_intraocular_pressure | 0.83743750 |
| 101 | MP0002396_abnormal_hematopoietic_system | 0.83582253 |
| 102 | MP0009379_abnormal_foot_pigmentation | 0.83157280 |
| 103 | MP0000163_abnormal_cartilage_morphology | 0.82161325 |
| 104 | MP0000538_abnormal_urinary_bladder | 0.82141672 |
| 105 | MP0005375_adipose_tissue_phenotype | 0.81978822 |
| 106 | MP0001299_abnormal_eye_distance/ | 0.81516880 |
| 107 | MP0006054_spinal_hemorrhage | 0.80984790 |
| 108 | MP0001270_distended_abdomen | 0.80140868 |
| 109 | MP0005275_abnormal_skin_tensile | 0.80059916 |
| 110 | MP0003950_abnormal_plasma_membrane | 0.80019364 |
| 111 | MP0001881_abnormal_mammary_gland | 0.78601967 |
| 112 | MP0002938_white_spotting | 0.78351909 |
| 113 | MP0001243_abnormal_dermal_layer | 0.78225740 |
| 114 | MP0002102_abnormal_ear_morphology | 0.78159996 |
| 115 | MP0004272_abnormal_basement_membrane | 0.77841544 |
| 116 | MP0001533_abnormal_skeleton_physiology | 0.77337869 |
| 117 | MP0004133_heterotaxia | 0.77026746 |
| 118 | MP0003953_abnormal_hormone_level | 0.76901075 |
| 119 | MP0005503_abnormal_tendon_morphology | 0.76871374 |
| 120 | MP0000631_abnormal_neuroendocrine_gland | 0.76724790 |
| 121 | MP0005164_abnormal_response_to | 0.76075963 |
| 122 | MP0001286_abnormal_eye_development | 0.76029634 |
| 123 | MP0001764_abnormal_homeostasis | 0.75841620 |
| 124 | MP0001324_abnormal_eye_pigmentation | 0.74545482 |
| 125 | MP0008995_early_reproductive_senescence | 0.73903603 |
| 126 | MP0002933_joint_inflammation | 0.72514207 |
| 127 | MP0001529_abnormal_vocalization | 0.72083171 |
| 128 | MP0002876_abnormal_thyroid_physiology | 0.71144536 |
| 129 | MP0004019_abnormal_vitamin_homeostasis | 0.70913410 |
| 130 | MP0008469_abnormal_protein_level | 0.69731286 |
| 131 | MP0000598_abnormal_liver_morphology | 0.69562341 |
| 132 | MP0000377_abnormal_hair_follicle | 0.69237772 |
| 133 | MP0003186_abnormal_redox_activity | 0.69094809 |
| 134 | MP0003806_abnormal_nucleotide_metabolis | 0.67543237 |
| 135 | MP0003656_abnormal_erythrocyte_physiolo | 0.66974661 |
| 136 | MP0009642_abnormal_blood_homeostasis | 0.66943536 |
| 137 | MP0002115_abnormal_skeleton_extremities | 0.66284806 |
| 138 | MP0002127_abnormal_cardiovascular_syste | 0.66151641 |
| 139 | MP0002971_abnormal_brown_adipose | 0.65530731 |
| 140 | MP0002098_abnormal_vibrissa_morphology | 0.64703962 |
| 141 | MP0005391_vision/eye_phenotype | 0.64527538 |
| 142 | MP0005551_abnormal_eye_electrophysiolog | 0.63873560 |
| 143 | MP0001293_anophthalmia | 0.63617613 |
| 144 | MP0003937_abnormal_limbs/digits/tail_de | 0.61163746 |
| 145 | MP0002006_tumorigenesis | 0.61147144 |
| 146 | MP0002177_abnormal_outer_ear | 0.60401552 |
| 147 | MP0003936_abnormal_reproductive_system | 0.60399975 |
| 148 | MP0009764_decreased_sensitivity_to | 0.60385865 |
| 149 | MP0003011_delayed_dark_adaptation | 0.57968154 |
| 150 | MP0005666_abnormal_adipose_tissue | 0.55999525 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 6.11425661 |
| 2 | Hyperinsulinemic hypoglycemia (HP:0000825) | 5.62653043 |
| 3 | Hypoglycemic seizures (HP:0002173) | 5.17013368 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.78530242 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 4.49649785 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 4.40525686 |
| 7 | Abnormality of the intrinsic pathway (HP:0010989) | 4.38381492 |
| 8 | Papillary thyroid carcinoma (HP:0002895) | 4.36679728 |
| 9 | Symptomatic seizures (HP:0011145) | 4.32453260 |
| 10 | Abnormality of the common coagulation pathway (HP:0010990) | 4.08514883 |
| 11 | Hyperglycemia (HP:0003074) | 3.66817451 |
| 12 | Conjugated hyperbilirubinemia (HP:0002908) | 3.56312623 |
| 13 | Xanthomatosis (HP:0000991) | 3.49457774 |
| 14 | Ketoacidosis (HP:0001993) | 3.33261960 |
| 15 | Volvulus (HP:0002580) | 3.27429792 |
| 16 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.19732191 |
| 17 | Chronic hepatic failure (HP:0100626) | 3.15297644 |
| 18 | Fat malabsorption (HP:0002630) | 3.03515685 |
| 19 | Bifid tongue (HP:0010297) | 2.98994925 |
| 20 | Thyroid carcinoma (HP:0002890) | 2.96931457 |
| 21 | Deep venous thrombosis (HP:0002625) | 2.96363579 |
| 22 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.94906156 |
| 23 | Ketosis (HP:0001946) | 2.87536240 |
| 24 | Generalized aminoaciduria (HP:0002909) | 2.86810232 |
| 25 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.84864868 |
| 26 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.84864868 |
| 27 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.81607689 |
| 28 | Abnormal ciliary motility (HP:0012262) | 2.77537041 |
| 29 | Hypoproteinemia (HP:0003075) | 2.76368445 |
| 30 | Late onset (HP:0003584) | 2.72806533 |
| 31 | Metaphyseal dysplasia (HP:0100255) | 2.71768507 |
| 32 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.71198673 |
| 33 | Bile duct proliferation (HP:0001408) | 2.69498466 |
| 34 | Abnormal biliary tract physiology (HP:0012439) | 2.69498466 |
| 35 | Myocardial infarction (HP:0001658) | 2.65404269 |
| 36 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.62309527 |
| 37 | Back pain (HP:0003418) | 2.60654702 |
| 38 | Joint hemorrhage (HP:0005261) | 2.59713992 |
| 39 | Renal cortical cysts (HP:0000803) | 2.59658482 |
| 40 | Protuberant abdomen (HP:0001538) | 2.57247086 |
| 41 | Hydroxyprolinuria (HP:0003080) | 2.54976736 |
| 42 | Abnormality of proline metabolism (HP:0010907) | 2.54976736 |
| 43 | Broad alveolar ridges (HP:0000187) | 2.54917940 |
| 44 | Decreased circulating renin level (HP:0003351) | 2.54561531 |
| 45 | Tubulointerstitial nephritis (HP:0001970) | 2.46780553 |
| 46 | Genital tract atresia (HP:0001827) | 2.41197071 |
| 47 | Pancreatic cysts (HP:0001737) | 2.37803471 |
| 48 | Hypothermia (HP:0002045) | 2.37659545 |
| 49 | Hyperkalemia (HP:0002153) | 2.35528453 |
| 50 | Chronic bronchitis (HP:0004469) | 2.35173834 |
| 51 | Broad palm (HP:0001169) | 2.34996301 |
| 52 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.34933722 |
| 53 | Agitation (HP:0000713) | 2.33552252 |
| 54 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.31248229 |
| 55 | Hypobetalipoproteinemia (HP:0003563) | 2.28591328 |
| 56 | Epidermoid cyst (HP:0200040) | 2.25009795 |
| 57 | Medial flaring of the eyebrow (HP:0010747) | 2.24233181 |
| 58 | Vaginal atresia (HP:0000148) | 2.23776634 |
| 59 | Premature rupture of membranes (HP:0001788) | 2.22347660 |
| 60 | Molar tooth sign on MRI (HP:0002419) | 2.20978419 |
| 61 | Abnormality of midbrain morphology (HP:0002418) | 2.20978419 |
| 62 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.20566105 |
| 63 | Mucopolysacchariduria (HP:0008155) | 2.20566105 |
| 64 | Thoracolumbar scoliosis (HP:0002944) | 2.20467304 |
| 65 | Abdominal distention (HP:0003270) | 2.20390889 |
| 66 | Rhinitis (HP:0012384) | 2.19261000 |
| 67 | Dysostosis multiplex (HP:0000943) | 2.18837814 |
| 68 | Beaking of vertebral bodies (HP:0004568) | 2.18780288 |
| 69 | Type I diabetes mellitus (HP:0100651) | 2.18027856 |
| 70 | Right ventricular cardiomyopathy (HP:0011663) | 2.16290169 |
| 71 | Steatorrhea (HP:0002570) | 2.14724850 |
| 72 | Hyperlipoproteinemia (HP:0010980) | 2.14208102 |
| 73 | Abnormality of the pubic bones (HP:0003172) | 2.13046099 |
| 74 | Papilledema (HP:0001085) | 2.12829741 |
| 75 | Skin nodule (HP:0200036) | 2.12026518 |
| 76 | True hermaphroditism (HP:0010459) | 2.10921539 |
| 77 | Abnormality of vitamin B metabolism (HP:0004340) | 2.09772339 |
| 78 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.07906765 |
| 79 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.07534914 |
| 80 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.07534914 |
| 81 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.07534914 |
| 82 | Vacuolated lymphocytes (HP:0001922) | 2.06946880 |
| 83 | Hypoplastic labia majora (HP:0000059) | 2.06257578 |
| 84 | Gingival bleeding (HP:0000225) | 2.05846594 |
| 85 | Joint swelling (HP:0001386) | 2.05801692 |
| 86 | Short nail (HP:0001799) | 2.02991360 |
| 87 | Gastrointestinal atresia (HP:0002589) | 2.02957512 |
| 88 | Congenital sensorineural hearing impairment (HP:0008527) | 2.01748915 |
| 89 | Insulin resistance (HP:0000855) | 1.99871626 |
| 90 | Abnormality of the renal medulla (HP:0100957) | 1.95874719 |
| 91 | Wide nose (HP:0000445) | 1.95872439 |
| 92 | Absent eyebrow (HP:0002223) | 1.95838531 |
| 93 | Pancreatitis (HP:0001733) | 1.95673981 |
| 94 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.95430717 |
| 95 | Pheochromocytoma (HP:0002666) | 1.95147136 |
| 96 | Menorrhagia (HP:0000132) | 1.95144211 |
| 97 | Spontaneous abortion (HP:0005268) | 1.94817184 |
| 98 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.94230341 |
| 99 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.94230341 |
| 100 | Testicular neoplasm (HP:0010788) | 1.93768776 |
| 101 | Abnormal biliary tract morphology (HP:0012440) | 1.93752338 |
| 102 | Congenital primary aphakia (HP:0007707) | 1.93120659 |
| 103 | Hyperglycinuria (HP:0003108) | 1.93045543 |
| 104 | Intestinal atresia (HP:0011100) | 1.92985236 |
| 105 | Abnormality of urine glucose concentration (HP:0011016) | 1.92644836 |
| 106 | Glycosuria (HP:0003076) | 1.92644836 |
| 107 | Arthropathy (HP:0003040) | 1.92556028 |
| 108 | Hypolipoproteinemia (HP:0010981) | 1.92506186 |
| 109 | Abnormality of purine metabolism (HP:0004352) | 1.91908586 |
| 110 | Abnormality of vitamin metabolism (HP:0100508) | 1.90263083 |
| 111 | Elevated alkaline phosphatase (HP:0003155) | 1.89782848 |
| 112 | Abnormality of the renal cortex (HP:0011035) | 1.89668350 |
| 113 | Exocrine pancreatic insufficiency (HP:0001738) | 1.89093237 |
| 114 | Macroorchidism (HP:0000053) | 1.88326091 |
| 115 | Neurofibrillary tangles (HP:0002185) | 1.88140301 |
| 116 | Large for gestational age (HP:0001520) | 1.87258181 |
| 117 | Restlessness (HP:0000711) | 1.86823022 |
| 118 | Bell-shaped thorax (HP:0001591) | 1.86525664 |
| 119 | Nephrogenic diabetes insipidus (HP:0009806) | 1.86025768 |
| 120 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.85774072 |
| 121 | Hyperphosphatemia (HP:0002905) | 1.85385981 |
| 122 | Pancreatic fibrosis (HP:0100732) | 1.85163909 |
| 123 | Hyperglycinemia (HP:0002154) | 1.84883989 |
| 124 | Hypoalphalipoproteinemia (HP:0003233) | 1.84529564 |
| 125 | Dicarboxylic aciduria (HP:0003215) | 1.83208329 |
| 126 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.83208329 |
| 127 | Submucous cleft hard palate (HP:0000176) | 1.82702883 |
| 128 | Tubular atrophy (HP:0000092) | 1.82150581 |
| 129 | Abnormality of the nasal septum (HP:0000419) | 1.80837055 |
| 130 | Nephronophthisis (HP:0000090) | 1.80481194 |
| 131 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.80075801 |
| 132 | Abnormality of glycine metabolism (HP:0010895) | 1.80075801 |
| 133 | Hypoplastic ischia (HP:0003175) | 1.79861487 |
| 134 | Male infertility (HP:0003251) | 1.79750161 |
| 135 | Gait imbalance (HP:0002141) | 1.78872959 |
| 136 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.78869064 |
| 137 | Gonadal dysgenesis (HP:0000133) | 1.78287295 |
| 138 | Proximal tubulopathy (HP:0000114) | 1.77980867 |
| 139 | Abnormality of incisor morphology (HP:0011063) | 1.77681236 |
| 140 | Sex reversal (HP:0012245) | 1.77335113 |
| 141 | Abnormal sex determination (HP:0012244) | 1.77335113 |
| 142 | Facial hemangioma (HP:0000329) | 1.76869187 |
| 143 | Retinal atrophy (HP:0001105) | 1.76542978 |
| 144 | Alacrima (HP:0000522) | 1.76151750 |
| 145 | Male pseudohermaphroditism (HP:0000037) | 1.75882360 |
| 146 | Cystic liver disease (HP:0006706) | 1.75842797 |
| 147 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.74790143 |
| 148 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.74702108 |
| 149 | Posterior subcapsular cataract (HP:0007787) | 1.73062584 |
| 150 | Menstrual irregularities (HP:0000858) | 1.71919985 |
| 151 | Enlarged kidneys (HP:0000105) | 1.71179398 |
| 152 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.70523052 |
| 153 | Bronchiectasis (HP:0002110) | 1.69491352 |
| 154 | Tubulointerstitial abnormality (HP:0001969) | 1.69126730 |
| 155 | Hypoplasia of dental enamel (HP:0006297) | 1.67194818 |
| 156 | Abnormality of potassium homeostasis (HP:0011042) | 1.66706184 |
| 157 | Complement deficiency (HP:0004431) | 1.66366415 |
| 158 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.66306554 |
| 159 | Neuroendocrine neoplasm (HP:0100634) | 1.64792711 |
| 160 | Abnormality of the labia majora (HP:0012881) | 1.62311770 |
| 161 | Osteomalacia (HP:0002749) | 1.61582153 |
| 162 | Wide intermamillary distance (HP:0006610) | 1.61082327 |
| 163 | Abnormal delivery (HP:0001787) | 1.61024001 |
| 164 | Blepharitis (HP:0000498) | 1.60922672 |
| 165 | Anophthalmia (HP:0000528) | 1.60820103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 4.85176868 |
| 2 | INSRR | 4.47262716 |
| 3 | MAPK15 | 3.77166858 |
| 4 | FRK | 3.16415762 |
| 5 | BCR | 3.10979392 |
| 6 | NUAK1 | 3.01706039 |
| 7 | ERN1 | 2.93352293 |
| 8 | IRAK3 | 2.53704925 |
| 9 | PASK | 2.44822830 |
| 10 | PIK3CG | 2.42118049 |
| 11 | TRIM28 | 2.28708325 |
| 12 | EPHA3 | 2.28133226 |
| 13 | LATS1 | 2.24188594 |
| 14 | TNIK | 2.16715062 |
| 15 | SIK2 | 2.13888034 |
| 16 | SIK1 | 2.09575869 |
| 17 | IRAK1 | 2.05021369 |
| 18 | ACVR1B | 1.91129247 |
| 19 | BCKDK | 1.89480010 |
| 20 | AKT3 | 1.87472605 |
| 21 | ERBB3 | 1.84828847 |
| 22 | PDK2 | 1.73682721 |
| 23 | PNCK | 1.68875407 |
| 24 | IRAK4 | 1.66333907 |
| 25 | PIK3CA | 1.65114561 |
| 26 | HIPK2 | 1.64805218 |
| 27 | WNK4 | 1.59698901 |
| 28 | MAP2K6 | 1.56061879 |
| 29 | STK24 | 1.33892067 |
| 30 | FGFR4 | 1.32437711 |
| 31 | FGFR1 | 1.32092155 |
| 32 | FLT3 | 1.31181690 |
| 33 | EPHB1 | 1.28291708 |
| 34 | CASK | 1.26106305 |
| 35 | MAP3K12 | 1.25184843 |
| 36 | MAP3K2 | 1.23426635 |
| 37 | CAMK1G | 1.20018442 |
| 38 | NLK | 1.17829296 |
| 39 | PBK | 1.13951337 |
| 40 | GRK1 | 1.11817464 |
| 41 | STK39 | 1.07575863 |
| 42 | PTK6 | 1.06451810 |
| 43 | TXK | 1.03616004 |
| 44 | MAP3K4 | 1.02860130 |
| 45 | IRAK2 | 1.01460639 |
| 46 | PDGFRA | 1.00083008 |
| 47 | TRPM7 | 1.00009521 |
| 48 | JAK3 | 0.97897653 |
| 49 | BRSK2 | 0.97696333 |
| 50 | MET | 0.96542460 |
| 51 | ERBB4 | 0.95838216 |
| 52 | YES1 | 0.92105949 |
| 53 | MKNK1 | 0.91273578 |
| 54 | TEC | 0.88280311 |
| 55 | PTK2 | 0.87543221 |
| 56 | BMPR1B | 0.85996569 |
| 57 | DYRK1B | 0.85985863 |
| 58 | MAP2K2 | 0.85742829 |
| 59 | PAK3 | 0.84649102 |
| 60 | FER | 0.84149562 |
| 61 | DMPK | 0.81701390 |
| 62 | WNK1 | 0.81652519 |
| 63 | OXSR1 | 0.81638947 |
| 64 | EIF2AK1 | 0.80975735 |
| 65 | TBK1 | 0.80447279 |
| 66 | GRK7 | 0.80199009 |
| 67 | NME2 | 0.78672244 |
| 68 | MST1R | 0.78267512 |
| 69 | MUSK | 0.77919987 |
| 70 | JAK1 | 0.76965468 |
| 71 | CHUK | 0.72597382 |
| 72 | CAMK1D | 0.72479229 |
| 73 | MST4 | 0.72010521 |
| 74 | GSK3A | 0.71594291 |
| 75 | WNK3 | 0.68026024 |
| 76 | ABL2 | 0.67901779 |
| 77 | PRKAA2 | 0.67759852 |
| 78 | STK38L | 0.67725976 |
| 79 | CSF1R | 0.67684569 |
| 80 | EIF2AK3 | 0.66853450 |
| 81 | PIM2 | 0.66133687 |
| 82 | BLK | 0.65347689 |
| 83 | CDK3 | 0.63184022 |
| 84 | SCYL2 | 0.62027631 |
| 85 | ATM | 0.61521365 |
| 86 | NEK9 | 0.60895068 |
| 87 | MAP3K1 | 0.59768711 |
| 88 | TYK2 | 0.59576565 |
| 89 | NTRK1 | 0.59434439 |
| 90 | MAPKAPK5 | 0.59404360 |
| 91 | CSNK1G1 | 0.58616487 |
| 92 | ERBB2 | 0.58458005 |
| 93 | PDGFRB | 0.57947723 |
| 94 | EPHA2 | 0.57605822 |
| 95 | CDC42BPA | 0.55304312 |
| 96 | PAK2 | 0.55196111 |
| 97 | STK3 | 0.55044741 |
| 98 | PINK1 | 0.54408163 |
| 99 | JAK2 | 0.52829370 |
| 100 | BMPR2 | 0.52545556 |
| 101 | EIF2AK2 | 0.52195313 |
| 102 | MKNK2 | 0.51390460 |
| 103 | PLK2 | 0.50702991 |
| 104 | CSNK1E | 0.50599116 |
| 105 | STK16 | 0.50385710 |
| 106 | MAP3K14 | 0.49538202 |
| 107 | IKBKE | 0.49079572 |
| 108 | ROCK1 | 0.48951469 |
| 109 | PRKCE | 0.48810047 |
| 110 | TGFBR1 | 0.48528358 |
| 111 | LMTK2 | 0.48181541 |
| 112 | KDR | 0.47962359 |
| 113 | CSNK1A1L | 0.47065928 |
| 114 | CSNK1D | 0.44836242 |
| 115 | MAP4K2 | 0.44807564 |
| 116 | SIK3 | 0.44297536 |
| 117 | NEK6 | 0.44201461 |
| 118 | MAP2K7 | 0.43308964 |
| 119 | FGFR2 | 0.42699648 |
| 120 | CSK | 0.42662703 |
| 121 | IGF1R | 0.39850117 |
| 122 | MAP3K3 | 0.39618245 |
| 123 | PRKCQ | 0.38587655 |
| 124 | CSNK1A1 | 0.37534401 |
| 125 | MTOR | 0.37303348 |
| 126 | PRKACB | 0.37246739 |
| 127 | ITK | 0.36023417 |
| 128 | ABL1 | 0.35836013 |
| 129 | RPS6KA4 | 0.35555798 |
| 130 | BRD4 | 0.35304890 |
| 131 | MYLK | 0.35088960 |
| 132 | NEK2 | 0.34321906 |
| 133 | DYRK1A | 0.34216183 |
| 134 | DDR2 | 0.33892971 |
| 135 | CDK9 | 0.33086187 |
| 136 | FGFR3 | 0.32757991 |
| 137 | TIE1 | 0.32736119 |
| 138 | BTK | 0.32559083 |
| 139 | MAPK10 | 0.32315922 |
| 140 | PRKG1 | 0.32135347 |
| 141 | PRKACA | 0.32020478 |
| 142 | RPS6KA5 | 0.31947453 |
| 143 | KIT | 0.31893679 |
| 144 | WEE1 | 0.30972645 |
| 145 | EGFR | 0.30823489 |
| 146 | PRKDC | 0.28994356 |
| 147 | SGK1 | 0.28404130 |
| 148 | PRKACG | 0.28397758 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 6.18965455 |
| 2 | Protein export_Homo sapiens_hsa03060 | 5.42895916 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.21429696 |
| 4 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.09815054 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.45858091 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.33810282 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.11884210 |
| 8 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.96669498 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.93871608 |
| 10 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.92270329 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.92058393 |
| 12 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90737697 |
| 13 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.88113151 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.75208161 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.68805926 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.60948663 |
| 17 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.51671481 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.47563227 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.44022926 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.36614957 |
| 21 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.36046876 |
| 22 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.34222444 |
| 23 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.31099460 |
| 24 | Circadian rhythm_Homo sapiens_hsa04710 | 1.28298233 |
| 25 | ABC transporters_Homo sapiens_hsa02010 | 1.27662404 |
| 26 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.20837255 |
| 27 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.20389177 |
| 28 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.19509753 |
| 29 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.19415657 |
| 30 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.18300373 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.14934361 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.13908639 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.10668293 |
| 34 | Retinol metabolism_Homo sapiens_hsa00830 | 1.07923461 |
| 35 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.05884691 |
| 36 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.04102637 |
| 37 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.02083542 |
| 38 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.01789347 |
| 39 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.01558009 |
| 40 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.99108393 |
| 41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.97434905 |
| 42 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.96644784 |
| 43 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.93194535 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 0.93110201 |
| 45 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.90615229 |
| 46 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.88932116 |
| 47 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.87321218 |
| 48 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.84316581 |
| 49 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.82778219 |
| 50 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.80819944 |
| 51 | Insulin secretion_Homo sapiens_hsa04911 | 0.80557847 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79651143 |
| 53 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.78841979 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.76418310 |
| 55 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.76011321 |
| 56 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.75946239 |
| 57 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.74403415 |
| 58 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.74203642 |
| 59 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.71459442 |
| 60 | Other glycan degradation_Homo sapiens_hsa00511 | 0.68641174 |
| 61 | Basal transcription factors_Homo sapiens_hsa03022 | 0.67311282 |
| 62 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.66880474 |
| 63 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.65991901 |
| 64 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.65805095 |
| 65 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.64829471 |
| 66 | Lysine degradation_Homo sapiens_hsa00310 | 0.64425013 |
| 67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63931252 |
| 68 | Insulin resistance_Homo sapiens_hsa04931 | 0.63708481 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.62117256 |
| 70 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.61302032 |
| 71 | Bile secretion_Homo sapiens_hsa04976 | 0.58711686 |
| 72 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.57615753 |
| 73 | RNA degradation_Homo sapiens_hsa03018 | 0.54655001 |
| 74 | Mineral absorption_Homo sapiens_hsa04978 | 0.53200190 |
| 75 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.52009239 |
| 76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.51366106 |
| 77 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.50004392 |
| 78 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49548284 |
| 79 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.49125240 |
| 80 | Prostate cancer_Homo sapiens_hsa05215 | 0.48630997 |
| 81 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.48407542 |
| 82 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.47567584 |
| 83 | Cocaine addiction_Homo sapiens_hsa05030 | 0.46137634 |
| 84 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.44581723 |
| 85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.44166406 |
| 86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42051938 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41384000 |
| 88 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.39472753 |
| 89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39173556 |
| 90 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.36491148 |
| 91 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.35338218 |
| 92 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34575861 |
| 93 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.33283903 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.32966351 |
| 95 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.32360739 |
| 96 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.30248477 |
| 97 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.29913868 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.29685098 |
| 99 | Phototransduction_Homo sapiens_hsa04744 | 0.29127471 |
| 100 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.27990253 |
| 101 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.25378997 |
| 102 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.25157398 |
| 103 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.25000792 |
| 104 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.23782381 |
| 105 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.22958591 |
| 106 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.21219452 |
| 107 | Sulfur relay system_Homo sapiens_hsa04122 | 0.20462926 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20208720 |
| 109 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.20146367 |
| 110 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.20032197 |
| 111 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.19724019 |
| 112 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.19451901 |
| 113 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.19420647 |
| 114 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.19351526 |
| 115 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.18942670 |
| 116 | Phagosome_Homo sapiens_hsa04145 | 0.18409533 |
| 117 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.18255260 |
| 118 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.16576784 |
| 119 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.16480906 |
| 120 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.16477186 |
| 121 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.16054604 |
| 122 | Adherens junction_Homo sapiens_hsa04520 | 0.14837183 |
| 123 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.13804441 |
| 124 | Long-term depression_Homo sapiens_hsa04730 | 0.11314590 |
| 125 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.10190100 |

